SOURCE: Axxess Pharma Inc.

Axxess Pharma Inc.

June 29, 2015 10:05 ET

Axxess Pharma Prepares for Strong Revenue Growth in 2nd Half of 2015 -- Fueled by Their Latest Line of Tapout Products and Up-Listing to the OTCQB Stock Exchange

Financial Audits to Be Completed and Submitted to FINRA Within 30 Days

TORONTO, ON--(Marketwired - Jun 29, 2015) - Axxess Pharma Inc. (OTC PINK: AXXE), a company that develops a variety of nutritional supplements and specialty pharmaceutical products through its subsidiary company AllStar Health Brands Inc., is pleased to announce management projects a strong finish to the second half of 2015.

Currently, 2015 has been a year of aggressive marketing and global approvals to sell their all-natural Tapout supplements. Axxess Pharma is also proud to be a licensee for Tapout, the official fitness and training partner of WWE (Worldwide Wrestling Entertainment). To view the joint venture between Authentic Brands Group, LLC and WWE for Tapout, please click on the link:

Management has now continued their growth by expanding their product line with new chocolate and peanut butter protein bars, pre-work out protein powders and new organic proteins. This latest product expansion comes at a time when supermarkets are preparing to sell Axxess Pharma's all-natural Tapout products in chain stores nationwide. In preparation for management's expansion into supermarkets, they have now reported they are in the final stage of completing their financial audits for up-listing to the more liquid OTCQB. Axxess Pharma anticipates audits will be completed within the next 30 days. Once audits are complete, management anticipates a quick up-listing to the OTCQB. There are many benefits to up-listing to the OTCQB. Some of these benefits include improved ease of trading, opportunity for increased liquidity and recognition by Wall Street brokers and major Financial Institutions.

Below are additional accomplishments by Axxess Pharma within the last 60 days.

  • May 26, 2015: Axxess Pharma Announces Re-Orders of Company's Products -, well-known as the World's largest on-line retailer, has frequently sold-out Axxess Pharma's Tapout product. This re-order was for the all-natural Tapout Pain Relief Line and Extreme Muscle supplements.
  • May 12, 2015: Axxess Pharma's All-Natural Tapout Products Now Available in Large North American Fitness Chain - The pilot program was initiated on April 27, 2015 and is currently generating strong sales within the two fitness centers. Axxess Pharma anticipates sales will remain strong and lead to the North American roll-out into all of the chain's 300 plus fitness centers across North America.
  • May 6, 2015: Research Firm Murphy Analytics Re-Initiates Coverage on Axxess Pharma, Inc. with "Positive Outlook" - Axxess Pharma Projects $2.5 Million in Year over Year Sales from May 2015 to May 2016
  • April 29, 2015: Axxess Pharma Signs Agreement to Expand Full Tapout Line Into Over 60 High Profile Shopping Centers Across Canada by Early Summer - Agreement Secured With "Nutrition House," Canada's Leading Health Product Franchise
  • April 22, 2015: Axxess Pharma Signs Major Manufacturing, Marketing and Distribution Agreement with Chinese Manufacturer - Management Projects Agreement to Generate Additional $525,000 USD in First Year Sales Starting in Third Quarter 2015.

Dr. Bagi, President of Axxess Pharma, stated: "We are thrilled to have consummated these very important recent events, and will continue to integrate the Tapout line of products into global platforms with our new partners. The TapouT product lines, which represent natural yet effective sports and fitness options, provide a perfect synergy for military bases around the world as well fitness centers, nutrition houses such as GNC, and supermarkets across North America." Dr. Bagi further stated, "2015 continues to be a strong year for our company. We anticipate further expansion of sales and marketing in 2016. We also look to complete our financial audits within 60 days and quickly move to the more liquid OTCQB stock exchange."

About Axxess Pharma Inc.:
Axxess Pharma Inc. is a Nevada Corporation operating through its wholly-owned Canadian Subsidiary: Axxess Pharma Canada Inc., headquartered in Toronto. Axxess is a specialty Health Care Products Company dedicated to improving health and quality of life by offering select medicines, nutritional supplements and over the counter remedies all across the Americas. Axxess's goal is to bring additional products to the market and provide new, innovative options for better health spanning areas such as high cholesterol, blood pressure, acute pain -- to optimal health management through improved nutritional supplements.

For more information, please visit, or contact Investor Relations at (973) 351-3868.

To view all Axxess Pharma social media sites, please click any of the following links:,,

Safe Harbor Statement
Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.

The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management, as well as assumptions made by any information currently available to the Company or its management. When used in this document, the words "anticipate," "estimate," "expect," "intend," "plans," "projects," and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks, estimated, expected, intended or projected. In each instance, forward-looking information should be and uncertainties.

Contact Information